ANNUAL RESULTS
GlaxoSmithKline Pharmaceuticals Ltd.
BSE
Jun 06
3431.50
-28.20 ( -0.82%)
Volume
5384
Prev. Close
3459.70
Open Price
3458.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 06
3438.50
-27.70 ( -0.80%)
Volume
149126
Prev. Close
3466.20
Open Price
3451.10
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Annual Results
for the last 5 years.
|
ISIN No
|
INE159A01016
|
Market Cap. ( ₹ in Cr. )
|
58250.26
|
P/BV
|
34.82
|
Book Value ( ₹ )
|
98.74
|
|
BSE Code
|
500660
|
52 Week High/Low ( ₹ )
|
3516/1921
|
FV/ML
|
10/1
|
P/E(X)
|
62.80
|
|
NSE Code
|
GLAXOEQ
|
Book Closure
|
30/05/2025
|
EPS ( ₹ )
|
54.75
|
Div Yield (%)
|
1.57
|
(₹ in Crs.)
| Net Sales/Income from operations | 3723.49 | 3407.25 | 3216.34 | 3217.51 | 3193.73 |
| Total Income From Operations | 3723.49 | 3407.25 | 3216.34 | 3217.51 | 3193.73 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 470.86 | 504.99 | 394.35 | 552.47 | 452.64 |
| Purchase of Traded Goods | 845.11 | 853.08 | 788.43 | 729.44 | 880.11 |
| Increase/Decrease in Stocks | 51.23 | -69.64 | 67.25 | 13.83 | -27.53 |
| Employees Cost | 579.70 | 624.39 | 594.99 | 610.23 | 614.69 |
| Depreciation | 66.79 | 69.68 | 65.77 | 68.19 | 79.28 |
| Other Expenses | 607.30 | 593.78 | 571.91 | 555.71 | 578.87 |
| Total Expenses | 2620.99 | 2576.28 | 2482.70 | 2529.87 | 2578.06 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 1102.50 | 830.97 | 733.64 | 687.64 | 615.67 |
| Other Income | 142.56 | 123.48 | 101.52 | 76.22 | 110.19 |
| P/L Before Interest, Excpt. Items & Tax | 1245.06 | 954.45 | 835.16 | 763.86 | 725.86 |
| Interest | 1.31 | 1.80 | 1.81 | 1.99 | 3.53 |
| P/L Before Exceptional Items & Tax | 1243.75 | 952.65 | 833.35 | 761.87 | 722.33 |
| Exceptional Items | 4.69 | -143.61 | -0.97 | 11.58 | -172.60 |
| P/L Before Tax | 1248.44 | 809.04 | 832.38 | 773.45 | 549.73 |
| Tax | 329.38 | 224.35 | 227.68 | 396.87 | 192.17 |
| P/L After Tax from Ordinary Activities | 919.06 | 584.69 | 604.70 | 376.58 | 357.56 |
| Extra Ordinary Item | 0.00 | 0.00 | 3.05 | 1313.95 | 0.00 |
| Net Profit/Loss For the Period | 919.06 | 584.69 | 607.75 | 1690.53 | 357.56 |
| | | | | | |
| Equity Share Capital | 169.41 | 169.41 | 169.41 | 169.41 | 169.41 |
| Reserves And Surplus | 1779.82 | 1623.69 | 1585.27 | 2508.21 | 1327.71 |
| Equity Dividend Rate | 540.00 | 320.00 | 320.00 | 900.00 | 300.00 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 54.01 | 40.83 | 35.90 | 99.79 | 21.11 |
| Diluted EPS (Rs.) | 54.24 | 34.51 | 35.90 | 99.79 | 21.11 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 54.01 | 40.83 | 35.88 | 99.79 | 21.11 |
| Diluted EPS (Rs.) | 54.24 | 34.51 | 35.88 | 99.79 | 21.11 |
| | | | | | |
| PBITOE Margin (%) | 29.60 | 24.38 | 22.80 | 21.37 | 19.27 |
| PBTE Margin (%) | 33.40 | 27.95 | 25.90 | 23.67 | 22.61 |
| PBT Margin (%) | 33.52 | 23.74 | 25.87 | 24.03 | 17.21 |
| PAT Margin (%) | 24.68 | 17.16 | 18.89 | 52.54 | 11.19 |